{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:39:13Z","timestamp":1792435153501,"version":"4.5.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangdong Drug Administration Science and technology innovation project","award":["2025TDB64"],"award-info":[{"award-number":["2025TDB64"]}]},{"name":"Science and Technology Program of Shenzhen","award":["JCYJ20230807151201004"],"award-info":[{"award-number":["JCYJ20230807151201004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00284-026-05136-1","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:42:03Z","timestamp":1792431723000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular Detection Technologies for Helicobacter pylori Antibiotic Resistance: Current Status and Clinical Implications"],"prefix":"10.1007","volume":"83","author":[{"given":"Zhenyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanni","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"key":"5136_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327745","author":"P Malfertheiner","year":"2022","unstructured":"Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou JM, Schulz C, Gasbarrini A, Hunt RH, Leja M, O\u2019Morain C, Rugge M, Suerbaum S, Tilg H, Sugano K, El-Omar EM (2022) Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report. Gut. https:\/\/doi.org\/10.1136\/gutjnl-2022-327745","journal-title":"Gut"},{"issue":"1","key":"5136_CR2","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1186\/s12879-022-07625-7","volume":"22","author":"V Tran","year":"2022","unstructured":"Tran V, Saad T, Tesfaye M, Walelign S, Wordofa M, Abera D, Desta K, Tsegaye A, Ay A, Taye B (2022) Helicobacter pylori (H. pylori) risk factor analysis and prevalence prediction: a machine learning-based approach. BMC Infect Dis 22(1):655. https:\/\/doi.org\/10.1186\/s12879-022-07625-7","journal-title":"BMC Infect Dis"},{"issue":"2","key":"5136_CR3","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1074\/mcp.RA118.001181","volume":"18","author":"JM Noto","year":"2019","unstructured":"Noto JM, Rose KL, Hachey AJ, Delgado AG, Romero-Gallo J, Wroblewski LE, Schneider BG, Shah SC, Cover TL, Wilson KT, Israel DA, Roa JC, Schey KL, Zavros Y, Piazuelo MB, Peek RM Jr. (2019) Carcinogenic Helicobacter pylori strains selectively dysregulate the in vivo gastric proteome, which may be associated with stomach cancer progression. Mol Cell Proteomics 18(2):352\u2013371. https:\/\/doi.org\/10.1074\/mcp.RA118.001181","journal-title":"Mol Cell Proteomics"},{"issue":"2","key":"5136_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12020191","volume":"12","author":"A Elbehiry","year":"2023","unstructured":"Elbehiry A, Marzouk E, Aldubaib M, Abalkhail A, Anagreyyah S, Anajirih N, Almuzaini AM, Rawway M, Alfadhel A, Draz A, Abu-Okail A (2023) Helicobacter pylori infection: current status and future prospects on diagnostic, therapeutic and control challenges. Antibiotics (Basel) 12(2):191. https:\/\/doi.org\/10.3390\/antibiotics12020191","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"5136_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/gutjnl-2020-321372","volume":"70","author":"OP Nyssen","year":"2021","unstructured":"Nyssen OP, Bordin D, Tepes B, P\u00e9rez-Aisa \u00c1, Vaira D, Caldas M, Bujanda L, Castro-Fernandez M, Lerang F, Leja M, Rodrigo L, Rokkas T, Kupcinskas L, P\u00e9rez-Lasala J, Jonaitis L, Shvets O, Gasbarrini A, Simsek H, Axon ATR, Buz\u00e1s G, Machado JC, Niv Y, Boyanova L, Goldis A, Lamy V, Tonkic A, Przytulski K, Beglinger C, Venerito M, Bytzer P, Capelle L, Milosavljevi\u0107 T, Milivojevic V, Veijola L, Molina-Infante J, Vologzhanina L, Fadeenko G, Ari\u00f1o I, Fiorini G, Garre A, Garrido J, C FP, Puig I, Heluwaert F, Megraud F, O\u2019Morain C, and Gisbert JP, (2021) European registry on helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients. Gut 70(1):40\u201354. https:\/\/doi.org\/10.1136\/gutjnl-2020-321372","journal-title":"Gut"},{"issue":"8","key":"5136_CR6","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1136\/gut.2009.192757","volume":"59","author":"DY Graham","year":"2010","unstructured":"Graham DY, Fischbach L (2010) Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 59(8):1143\u201353. https:\/\/doi.org\/10.1136\/gut.2009.192757","journal-title":"Gut"},{"issue":"2","key":"5136_CR7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/ajg.2016.563","volume":"112","author":"WD Chey","year":"2017","unstructured":"Chey WD, Leontiadis GI, Howden CW, Moss SF (2017) ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol 112(2):212\u2013239. https:\/\/doi.org\/10.1038\/ajg.2016.563","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"5136_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1053\/j.gastro.2016.04.006","volume":"151","author":"CA Fallone","year":"2016","unstructured":"Fallone CA, Chiba N, van Zanten SV, Fischbach L, Gisbert JP, Hunt RH, Jones NL, Render C, Leontiadis GI, Moayyedi P, Marshall JK (2016) The Toronto consensus for the treatment of Helicobacter pylori infection in adults. Gastroenterology 151(1):51-69.e14. https:\/\/doi.org\/10.1053\/j.gastro.2016.04.006","journal-title":"Gastroenterology"},{"issue":"4","key":"5136_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12699","volume":"25","author":"L Luo","year":"2020","unstructured":"Luo L, Huang Y, Liang X, Ji Y, Yu L, Lu H (2020) Susceptibility-guided therapy for Helicobacter pylori-infected penicillin-allergic patients: a prospective clinical trial of first-line and rescue therapies. Helicobacter 25(4):e12699. https:\/\/doi.org\/10.1111\/hel.12699","journal-title":"Helicobacter"},{"issue":"3","key":"5136_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1523-5378.2010.00758.x","volume":"15","author":"Q Sun","year":"2010","unstructured":"Sun Q, Liang X, Zheng Q, Liu W, Xiao S, Gu W, Lu H (2010) High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication. Helicobacter 15(3):233\u20138","journal-title":"Helicobacter"},{"issue":"7","key":"5136_CR11","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.14309\/ajg.0000000000002255","volume":"118","author":"PI Hsu","year":"2023","unstructured":"Hsu PI, Chen KY, Tai WC, Yang JC, Tsay FW, Liu YH, Chen CL, Lee CL, Yeh HZ, Kuo CH, Chuah SK, Lee HC, Shie CB, Shiu SI, Kao JY, Yamaoka Y, Graham DY, Wu DC (2023) Hybrid, high-dose dual and bismuth quadruple therapies for first-line treatment of Helicobacter pylori infection in Taiwan: a multicenter, open-label, randomized trial. Am J Gastroenterol 118(7):1184\u20131195. https:\/\/doi.org\/10.14309\/ajg.0000000000002255","journal-title":"Am J Gastroenterol"},{"key":"5136_CR12","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.2147\/idr.S357473","volume":"15","author":"C Hou","year":"2022","unstructured":"Hou C, Yin F, Wang S, Zhao A, Li Y, Liu Y (2022) Helicobacter pylori biofilm-related drug resistance and new developments in its anti-biofilm agents. Infect Drug Resist 15:1561\u20131571. https:\/\/doi.org\/10.2147\/idr.S357473","journal-title":"Infect Drug Resist"},{"issue":"4","key":"5136_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12715","volume":"25","author":"Y Cai","year":"2020","unstructured":"Cai Y, Wang C, Chen Z, Xu Z, Li H, Li W, Sun Y (2020) Transporters HP0939, HP0497, and HP0471 participate in intrinsic multidrug resistance and biofilm formation in Helicobacter pylori by enhancing drug efflux. Helicobacter 25(4):e12715. https:\/\/doi.org\/10.1111\/hel.12715","journal-title":"Helicobacter"},{"key":"5136_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.913436","volume":"13","author":"OP Nyssen","year":"2022","unstructured":"Nyssen OP, Espada M, Gisbert JP (2022) Empirical vs. susceptibility-guided treatment of Helicobacter pylori infection: a systematic review and meta-analysis. Front Microbiol 13:913436. https:\/\/doi.org\/10.3389\/fmicb.2022.913436","journal-title":"Front Microbiol"},{"issue":"10","key":"5136_CR15","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1136\/gutjnl-2021-324032","volume":"70","author":"F Megraud","year":"2021","unstructured":"Megraud F, Bruyndonckx R, Coenen S, Wittkop L, Huang TD, Hoebeke M, B\u00e9n\u00e9jat L, Lehours P, Goossens H, Glupczynski Y (2021) Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community. Gut 70(10):1815\u20131822. https:\/\/doi.org\/10.1136\/gutjnl-2021-324032","journal-title":"Gut"},{"issue":"1","key":"5136_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/hel.13038","volume":"29","author":"W Xu","year":"2024","unstructured":"Xu W, Yang B, Lin L, Lin Q, Wang H, Yang L, Li Z, Lamm S, Chen Y, Yang N, Chen Y, Yu C, Li L (2024) Antibiotic resistance of Helicobacter pylori in Chinese children: a multicenter study from 2016 to 2023. Helicobacter 29(1):e13038. https:\/\/doi.org\/10.1111\/hel.13038","journal-title":"Helicobacter"},{"issue":"4","key":"5136_CR17","doi-asserted-by":"publisher","first-page":"e12592","DOI":"10.1111\/hel.12592","volume":"24","author":"JH Lee","year":"2019","unstructured":"Lee JH, Ahn JY, Choi KD, Jung HY, Kim JM, Baik GH, Kim BW, Park JC, Jung HK, Cho SJ, Shin CM, Choi YJ, Lee SH, Kim JH, Lee WS, Sung JK, Chung JW, Cheung DY, Lee H, Min YW, Kim JJ, Kim SY (2019) Nationwide antibiotic resistance mapping of helicobacter pylori in Korea: a prospective multicenter study. Helicobacter 24(4):e12592. https:\/\/doi.org\/10.1111\/hel.12592","journal-title":"Helicobacter"},{"issue":"5","key":"5136_CR18","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1053\/j.gastro.2018.07.007","volume":"155","author":"A Savoldi","year":"2018","unstructured":"Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E (2018) Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions. Gastroenterology 155(5):1372-1382.e17. https:\/\/doi.org\/10.1053\/j.gastro.2018.07.007","journal-title":"Gastroenterology"},{"issue":"8","key":"5136_CR19","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.14309\/ajg.0000000000001828","volume":"117","author":"JJC Ho","year":"2022","unstructured":"Ho JJC, Navarro M, Sawyer K, Elfanagely Y, Moss SF (2022) Helicobacter pylori antibiotic resistance in the United States between 2011 and 2021: a systematic review and meta-analysis. Am J Gastroenterol 117(8):1221\u20131230. https:\/\/doi.org\/10.14309\/ajg.0000000000001828","journal-title":"Am J Gastroenterol"},{"key":"5136_CR20","doi-asserted-by":"publisher","first-page":"621791","DOI":"10.3389\/fmicb.2020.621791","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Deng J, Wang Z, Li H, Wan C (2020) Antibiotic resistance of helicobacter pylori strains isolated from pediatric patients in southwest China. Front Microbiol 11:621791. https:\/\/doi.org\/10.3389\/fmicb.2020.621791","journal-title":"Front Microbiol"},{"issue":"2","key":"5136_CR21","doi-asserted-by":"publisher","first-page":"e0198721","DOI":"10.1128\/spectrum.01987-21","volume":"10","author":"Y Liu","year":"2022","unstructured":"Liu Y, Yang F, Wang S, Chi W, Ding L, Liu T, Zhu F, Ji D, Zhou J, Fang Y, Zhang J, Xiang P, Zhang Y, Zhao H (2022) HopE and HopD porin-mediated drug influx contributes to intrinsic antimicrobial susceptibility and inhibits streptomycin resistance acquisition by natural transformation in helicobacter pylori. Microbiol Spectr 10(2):e0198721. https:\/\/doi.org\/10.1128\/spectrum.01987-21","journal-title":"Microbiol Spectr"},{"key":"5136_CR22","doi-asserted-by":"publisher","unstructured":"Shu X, Ye D, Hu C, Peng K, Zhao H, Li H, and Jiang M(2022) Alarming antibiotics resistance of Helicobacter pylori from children in southeast China over 6\u00a0years. Sci Rep 12(1): 17754.https:\/\/doi.org\/10.1038\/s41598-022-21661-y","DOI":"10.1038\/s41598-022-21661-y"},{"issue":"4","key":"5136_CR23","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1053\/j.gastro.2023.12.022","volume":"166","author":"YC Chen","year":"2024","unstructured":"Chen YC, Malfertheiner P, Yu HT, Kuo CL, Chang YY, Meng FT, Wu YX, Hsiao JL, Chen MJ, Lin KP, Wu CY, Lin JT, O\u2019Morain C, Megraud F, Lee WC, El-Omar EM, Wu MS, Liou JM (2024) global prevalence of helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022. Gastroenterology 166(4):605\u2013619. https:\/\/doi.org\/10.1053\/j.gastro.2023.12.022","journal-title":"Gastroenterology"},{"issue":"1","key":"5136_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03816-y","volume":"22","author":"A Salahi-Niri","year":"2024","unstructured":"Salahi-Niri A, Nabavi-Rad A, Monaghan TM, Rokkas T, Doulberis M, Sadeghi A, Zali MR, Yamaoka Y, Tacconelli E, Yadegar A (2024) Global prevalence of Helicobacter pylori antibiotic resistance among children in the World Health Organization regions between 2000 and 2023: a systematic review and meta-analysis. BMC Med 22(1):598. https:\/\/doi.org\/10.1186\/s12916-024-03816-y","journal-title":"BMC Med"},{"issue":"6","key":"5136_CR25","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/s2468-1253(23)00070-5","volume":"8","author":"Y Li","year":"2023","unstructured":"Li Y, Choi H, Leung K, Jiang F, Graham DY, Leung WK (2023) Global prevalence of helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis. Lancet Gas Hepatol 8(6):553\u2013564. https:\/\/doi.org\/10.1016\/s2468-1253(23)00070-5","journal-title":"Lancet Gas Hepatol"},{"issue":"1","key":"5136_CR26","doi-asserted-by":"publisher","first-page":"101217","DOI":"10.1016\/j.lanmic.2025.101217","volume":"7","author":"FJ Mart\u00ednez-Mart\u00ednez","year":"2026","unstructured":"Mart\u00ednez-Mart\u00ednez FJ, Chiner-Oms \u00c1, Furi\u00f3 V, Yamaoka Y, Dekker JP, M\u00e9graud F, B\u00e9n\u00e9jat L, Ducournau A, Giese A, Jehanne Q, Jauvain M, Camargo MC, Comas I, Lehours P (2026) Genomic determinants of antibiotic resistance for helicobacter pylori treatment: a retrospective phenotypic and genotypic observational study. Lancet Microbe 7(1):101217. https:\/\/doi.org\/10.1016\/j.lanmic.2025.101217","journal-title":"Lancet Microbe"},{"issue":"12","key":"5136_CR27","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1136\/gut.2006.091272","volume":"55","author":"S Koletzko","year":"2006","unstructured":"Koletzko S, Richy F, Bontems P, Crone J, Kalach N, Monteiro ML, Gottrand F, Celinska-Cedro D, Roma-Giannikou E, Orderda G, Kolacek S, Urruzuno P, Mart\u00ednez-G\u00f3mez MJ, Casswall T, Ashorn M, Bodanszky H, M\u00e9graud F (2006) Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe. Gut 55(12):1711\u20136. https:\/\/doi.org\/10.1136\/gut.2006.091272","journal-title":"Gut"},{"issue":"6","key":"5136_CR28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/s0924-8579(01)00455-1","volume":"18","author":"G Mlynarczyk","year":"2001","unstructured":"Mlynarczyk G, Mlynarczyk A, Jeljaszewicz J (2001) Epidemiological aspects of antibiotic resistance in respiratory pathogens. Int J Antimicrob Agents 18(6):497\u2013502. https:\/\/doi.org\/10.1016\/s0924-8579(01)00455-1","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"5136_CR29","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1080\/17512433.2023.2282061","volume":"16","author":"T Rokkas","year":"2023","unstructured":"Rokkas T, Ekmektzoglou K (2023) Advances in the pharmacological and regulatory management of multidrug resistant helicobacter pylori. Expert Rev Clin Pharmacol 16(12):1229\u20131237","journal-title":"Expert Rev Clin Pharmacol"},{"key":"5136_CR30","doi-asserted-by":"publisher","first-page":"e11518","DOI":"10.7717\/peerj.11518","volume":"9","author":"SM Puah","year":"2021","unstructured":"Puah SM, Goh KL, Ng HK, Chua KH (2021) Current status of helicobacter pylori resistance to clarithromycin and levofloxacin in Malaysia-findings from a molecular based study. PeerJ 9:e11518. https:\/\/doi.org\/10.7717\/peerj.11518","journal-title":"PeerJ"},{"key":"5136_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-020-00373-6","volume":"12","author":"Y Li","year":"2020","unstructured":"Li Y, Lv T, He C, Wang H, Cram DS, Zhou L, Zhang J, Jiang W (2020) Evaluation of multiplex ARMS-PCR for detection of Helicobacter pylori mutations conferring resistance to clarithromycin and levofloxacin. Gut Pathog 12:35. https:\/\/doi.org\/10.1186\/s13099-020-00373-6","journal-title":"Gut Pathog"},{"issue":"1","key":"5136_CR32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s00284-020-02295-7","volume":"78","author":"H Alavifard","year":"2021","unstructured":"Alavifard H, Mirzaei N, Yadegar A, Baghaei K, Smith SM, Sadeghi A, Zali MR (2021) Investigation of clarithromycin resistance-associated mutations and virulence genotypes of Helicobacter pylori isolated from Iranian population: a cross-sectional study. Curr Microbiol 78(1):244\u2013254. https:\/\/doi.org\/10.1007\/s00284-020-02295-7","journal-title":"Curr Microbiol"},{"issue":"5","key":"5136_CR33","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s12275-013-3029-5","volume":"51","author":"R Smiley","year":"2013","unstructured":"Smiley R, Bailey J, Sethuraman M, Posecion N, Showkat Ali M (2013) Comparative proteomics analysis of sarcosine insoluble outer membrane proteins from clarithromycin resistant and sensitive strains of Helicobacter pylori. J Microbiol 51(5):612\u20138. https:\/\/doi.org\/10.1007\/s12275-013-3029-5","journal-title":"J Microbiol"},{"issue":"Suppl 1","key":"5136_CR34","first-page":"S75","volume":"25","author":"K Hirata","year":"2010","unstructured":"Hirata K, Suzuki H, Nishizawa T, Tsugawa H, Muraoka H, Saito Y, Matsuzaki J, Hibi T (2010) Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori. J Gastroenterol Hepatol 25(Suppl 1):S75-9","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"5136_CR35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/jac\/dkx351","volume":"73","author":"SA Dingsdag","year":"2018","unstructured":"Dingsdag SA, Hunter N (2018) Metronidazole: an update on metabolism, structure-cytotoxicity and resistance mechanisms. J Antimicrob Chemother 73(2):265\u2013279. https:\/\/doi.org\/10.1093\/jac\/dkx351","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"5136_CR36","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1128\/aac.44.8.2133-2142.2000","volume":"44","author":"DH Kwon","year":"2000","unstructured":"Kwon DH, El-Zaatari FA, Kato M, Osato MS, Reddy R, Yamaoka Y, Graham DY (2000) Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori. Antimicrob Agents Chemother 44(8):2133\u201342. https:\/\/doi.org\/10.1128\/aac.44.8.2133-2142.2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"5136_CR37","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1046\/j.1365-2958.1998.00806.x","volume":"28","author":"A Goodwin","year":"1998","unstructured":"Goodwin A, Kersulyte D, Sisson G, Veldhuyzen van Zanten SJ, Berg DE, Hoffman PS (1998) Metronidazole resistance in helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase. Mol Microbiol 28(2):383\u201393","journal-title":"Mol Microbiol"},{"issue":"6","key":"5136_CR38","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1111\/jgh.15352","volume":"36","author":"JP Schubert","year":"2021","unstructured":"Schubert JP, Gehlert J, Rayner CK, Roberts-Thomson IC, Costello S, Mangoni AA, Bryant RV (2021) Antibiotic resistance of Helicobacter pylori in Australia and New Zealand: a systematic review and meta-analysis. J Gastroenterol Hepatol 36(6):1450\u20131456. https:\/\/doi.org\/10.1111\/jgh.15352","journal-title":"J Gastroenterol Hepatol"},{"key":"5136_CR39","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2021.210843","author":"T Ziver-Sarp","year":"2021","unstructured":"Ziver-Sarp T, Yuksel-Mayda P, Saribas S, Demiryas S, Gareayaghi N, Ergin S, Tasci I, Ozbey D, Bal K, Erzin Y, Akkus S, Bahar-Tokman H, Demirci M, Tufan-Kocak B, Kocazeybek B (2021) Point mutations at gyrA and gyrB genes of levofloxacin resistant helicobacter pylori strains and dual resistance with clarithromycin. Clin Lab. https:\/\/doi.org\/10.7754\/Clin.Lab.2021.210843","journal-title":"Clin Lab"},{"issue":"5","key":"5136_CR40","doi-asserted-by":"publisher","first-page":"e03203","DOI":"10.1128\/jcm.03203-20","volume":"59","author":"A Mannion","year":"2021","unstructured":"Mannion A, Dzink-Fox J, Shen Z, Piazuelo MB, Wilson KT, Correa P, Peek RM Jr, Camargo MC, Fox JG (2021) Helicobacter pylori antimicrobial resistance and gene variants in high- and low-gastric-cancer-risk populations. J Clin Microbiol 59(5):e03203-20. https:\/\/doi.org\/10.1128\/jcm.03203-20","journal-title":"J Clin Microbiol"},{"issue":"16","key":"5136_CR41","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.1128\/jb.181.16.5107-5110.1999","volume":"181","author":"P Krishnamurthy","year":"1999","unstructured":"Krishnamurthy P, Parlow MH, Schneider J, Burroughs S, Wickland C, Vakil NB, Dunn BE, Phadnis SH (1999) Identification of a novel penicillin-binding protein from Helicobacter pylori. J Bacteriol 181(16):5107\u201310. https:\/\/doi.org\/10.1128\/jb.181.16.5107-5110.1999","journal-title":"J Bacteriol"},{"issue":"6","key":"5136_CR42","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/jac\/dkf140","volume":"50","author":"T Okamoto","year":"2002","unstructured":"Okamoto T, Yoshiyama H, Nakazawa T, Park ID, Chang MW, Yanai H, Okita K, Shirai M (2002) A change in PBP1 is involved in amoxicillin resistance of clinical isolates of helicobacter pylori. J Antimicrob Chemother 50(6):849\u201356. https:\/\/doi.org\/10.1093\/jac\/dkf140","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"5136_CR43","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/jac\/dkn051","volume":"61","author":"E Rimbara","year":"2008","unstructured":"Rimbara E, Noguchi N, Kawai T, Sasatsu M (2008) Mutations in penicillin-binding proteins 1, 2 and 3 are responsible for amoxicillin resistance in Helicobacter pylori. J Antimicrob Chemother 61(5):995\u20138. https:\/\/doi.org\/10.1093\/jac\/dkn051","journal-title":"J Antimicrob Chemother"},{"key":"5136_CR44","doi-asserted-by":"publisher","first-page":"175628482514043","DOI":"10.1177\/17562848251404379","volume":"18","author":"CY Lin","year":"2025","unstructured":"Lin CY, Kuo CJ, Lai CH, Lin WP, Chen CW, Lin WR, Chang ML, Ho YP, Huang SW, Su MY, Chiu CT, Chu YY (2025) Emergence of amoxicillin resistance in refractory helicobacter pylori infection. Ther Adv Gastroenterol 18:17562848251404380. https:\/\/doi.org\/10.1177\/17562848251404379","journal-title":"Ther Adv Gastroenterol"},{"issue":"9","key":"5136_CR45","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/j.1365-2362.2009.02166.x","volume":"39","author":"YS Tseng","year":"2009","unstructured":"Tseng YS, Wu DC, Chang CY, Kuo CH, Yang YC, Jan CM, Su YC, Kuo FC, Chang LL (2009) Amoxicillin resistance with beta-lactamase production in helicobacter pylori. Eur J Clin Invest 39(9):807\u201312","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"5136_CR46","doi-asserted-by":"publisher","first-page":"2379439","DOI":"10.1080\/19490976.2024.2379439","volume":"16","author":"X Gong","year":"2024","unstructured":"Gong X, Wang Y, An Y, Li Z, Liu D, Yong X (2024) The crosstalk between efflux pump and resistance gene mutation in helicobacter pylori. Gut Microbes 16(1):2379439. https:\/\/doi.org\/10.1080\/19490976.2024.2379439","journal-title":"Gut Microbes"},{"key":"5136_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14101044","author":"M Villegas","year":"2025","unstructured":"Villegas M, Ortega C, G\u00f3mez K, Cerda A, Sep\u00falveda R, Lara C, Bustamante L, Garcia D, Coppelli L, Hofmann E, Sierralta A, Pavez M (2025) High prevalence of hefA efflux pump overexpression in isolates of Helicobacter pylori resistant to clarithromycin. Antibiotics (Basel). https:\/\/doi.org\/10.3390\/antibiotics14101044","journal-title":"Antibiotics (Basel)"},{"issue":"2","key":"5136_CR48","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1128\/mmbr.65.2.232-260.2001","volume":"65","author":"I Chopra","year":"2001","unstructured":"Chopra I, Roberts M (2001) Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 65(2):232\u201360. https:\/\/doi.org\/10.1128\/mmbr.65.2.232-260.2001","journal-title":"Microbiol Mol Biol Rev"},{"issue":"2","key":"5136_CR49","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1128\/aac.49.2.578-583.2005","volume":"49","author":"JY Wu","year":"2005","unstructured":"Wu JY, Kim JJ, Reddy R, Wang WM, Graham DY, Kwon DH (2005) Tetracycline-resistant clinical Helicobacter pylori isolates with and without mutations in 16S rRNA-encoding genes. Antimicrob Agents Chemother 49(2):578\u201383. https:\/\/doi.org\/10.1128\/aac.49.2.578-583.2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"5136_CR50","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1128\/jb.184.8.2131-2140.2002","volume":"184","author":"CA Trieber","year":"2002","unstructured":"Trieber CA, Taylor DE (2002) Mutations in the 16S rRNA genes of Helicobacter pylori mediate resistance to tetracycline. J Bacteriol 184(8):2131\u201340. https:\/\/doi.org\/10.1128\/jb.184.8.2131-2140.2002","journal-title":"J Bacteriol"},{"issue":"4","key":"5136_CR51","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4103\/0255-0857.55452","volume":"27","author":"T Falsafi","year":"2009","unstructured":"Falsafi T, Ehsani A, Niknam V (2009) The role of active efflux in antibiotic - resistance of clinical isolates of Helicobacter pylori. Indian J Med Microbiol 27(4):335\u201340. https:\/\/doi.org\/10.4103\/0255-0857.55452","journal-title":"Indian J Med Microbiol"},{"issue":"Pt 10","key":"5136_CR52","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1099\/jmm.0.010876-0","volume":"58","author":"M Anoushiravani","year":"2009","unstructured":"Anoushiravani M, Falsafi T, Niknam V (2009) Proton motive force-dependent efflux of tetracycline in clinical isolates of Helicobacter pylori. J Med Microbiol 58(Pt 10):1309\u20131313. https:\/\/doi.org\/10.1099\/jmm.0.010876-0","journal-title":"J Med Microbiol"},{"issue":"11","key":"5136_CR53","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1093\/jac\/dkx257","volume":"72","author":"HI Kwon","year":"2017","unstructured":"Kwon HI, Kim S, Oh MH, Na SH, Kim YJ, Jeon YH, Lee JC (2017) Outer membrane protein A contributes to antimicrobial resistance of Acinetobacter baumannii through the OmpA-like domain. J Antimicrob Chemother 72(11):3012\u20133015. https:\/\/doi.org\/10.1093\/jac\/dkx257","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"5136_CR54","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1128\/jb.177.4.998-1007.1995","volume":"177","author":"DG Thanassi","year":"1995","unstructured":"Thanassi DG, Suh GS, Nikaido H (1995) Role of outer membrane barrier in efflux-mediated tetracycline resistance of Escherichia coli. J Bacteriol 177(4):998\u20131007. https:\/\/doi.org\/10.1128\/jb.177.4.998-1007.1995","journal-title":"J Bacteriol"},{"issue":"1","key":"5136_CR55","doi-asserted-by":"publisher","first-page":"2618860","DOI":"10.1080\/19490976.2026.2618860","volume":"18","author":"R Pathirana","year":"2026","unstructured":"Pathirana R, Capitani N, McCrory C, Della Bella C, Stuart I, Gilmore W, Bitto NJ, Tate MD, Johnston EL, Zavan L, Batinovic S, Pedersen J, Norden S, Chaudhry H, Ferrero RL, Korman TM, Greening D, O\u2019Brien-Simpson N, Ellisdon AM, Whisstock JC, Petrovski S, Taylor RA, D\u2019Elios MM, Nold-Petry CA, Nold MF, Kaparakis-Liaskos M (2026) Helicobacter pylori induces the production of interleukin-37 to promote broad immunosuppression and enhance colonization. Gut Microbes 18(1):2618860. https:\/\/doi.org\/10.1080\/19490976.2026.2618860","journal-title":"Gut Microbes"},{"key":"5136_CR56","doi-asserted-by":"publisher","unstructured":"El-Serag HB, Kao JY, Kanwal F, Gilger M, LoVecchio F, Moss SF, Crowe SE, Elfant A, Haas T, Hapke RJ, and Graham DY(2018) Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States. Clin Gastroenterol Hepatol 16(7): 992-1002.e6.https:\/\/doi.org\/10.1016\/j.cgh.2018.03.013","DOI":"10.1016\/j.cgh.2018.03.013"},{"issue":"5","key":"5136_CR57","doi-asserted-by":"publisher","first-page":"385","DOI":"10.4103\/sjg.sjg_638_21","volume":"28","author":"Z Yin","year":"2022","unstructured":"Yin Z, Xiao S, Tian X, Yuan Z, Zhou L (2022) The necessity and appropriate range of the diagnostic \u201cgray zone\u201d of (13)C-urea breath test. Saudi J Gastroenterol 28(5):385\u2013392. https:\/\/doi.org\/10.4103\/sjg.sjg_638_21","journal-title":"Saudi J Gastroenterol"},{"issue":"8","key":"5136_CR58","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1111\/j.1572-0241.2006.00668.x","volume":"101","author":"JP Gisbert","year":"2006","unstructured":"Gisbert JP, de la Morena F, Abraira V (2006) Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis. Am J Gastroenterol 101(8):1921\u201330","journal-title":"Am J Gastroenterol"},{"key":"5136_CR59","doi-asserted-by":"publisher","unstructured":"Della Bella C, D\u2019Elios S, Coletta S, Benagiano M, Azzurri A, Cianchi F, de Bernard M, and D\u2019Elios MM(2023) Increased IL-17A Serum Levels and Gastric Th17 Cells in Helicobacter pylori-Infected Patients with Gastric Premalignant Lesions. Cancers (Basel) 15(6).https:\/\/doi.org\/10.3390\/cancers15061662","DOI":"10.3390\/cancers15061662"},{"issue":"1","key":"5136_CR60","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/jac\/32.1.45","volume":"32","author":"AM Hirschl","year":"1993","unstructured":"Hirschl AM, Hirschl MM, Rotter ML (1993) Comparison of three methods for the determination of the sensitivity of helicobacter pylori to metronidazole. J Antimicrob Chemother 32(1):45\u20139. https:\/\/doi.org\/10.1093\/jac\/32.1.45","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"5136_CR61","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/s1473-3099(06)70627-2","volume":"6","author":"MM Gerrits","year":"2006","unstructured":"Gerrits MM, van Vliet AH, Kuipers EJ, Kusters JG (2006) Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect Dis 6(11):699\u2013709. https:\/\/doi.org\/10.1016\/s1473-3099(06)70627-2","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"5136_CR62","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/apt.13497","volume":"43","author":"I Thung","year":"2016","unstructured":"Thung I, Aramin H, Vavinskaya V, Gupta S, Park JY, Crowe SE, Valasek MA (2016) Review article: the global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther 43(4):514\u201333. https:\/\/doi.org\/10.1111\/apt.13497","journal-title":"Aliment Pharmacol Ther"},{"issue":"16","key":"5136_CR63","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.3748\/wjg.v23.i16.2854","volume":"23","author":"N Arslan","year":"2017","unstructured":"Arslan N, Y\u0131lmaz \u00d6, Demiray-G\u00fcrb\u00fcz E (2017) Importance of antimicrobial susceptibility testing for the management of eradication in helicobacter pylori infection. World J Gas 23(16):2854\u20132869. https:\/\/doi.org\/10.3748\/wjg.v23.i16.2854","journal-title":"World J Gas"},{"issue":"2","key":"5136_CR64","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12873","volume":"27","author":"H Li","year":"2022","unstructured":"Li H, Shen Y, Song X, Tang X, Hu R, Marshall BJ, Tang H, Benghezal M (2022) Need for standardization and harmonization of Helicobacter pylori antimicrobial susceptibility testing. Helicobacter 27(2):e12873. https:\/\/doi.org\/10.1111\/hel.12873","journal-title":"Helicobacter"},{"issue":"1","key":"5136_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2024.116237","volume":"109","author":"ST Orszulik","year":"2024","unstructured":"Orszulik ST (2024) The quality of antimicrobial susceptibility test discs and implications for clinical outcomes. Diagn Microbiol Infect Dis 109(1):116237. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116237","journal-title":"Diagn Microbiol Infect Dis"},{"key":"5136_CR66","doi-asserted-by":"publisher","first-page":"801537","DOI":"10.3389\/fmicb.2022.801537","volume":"13","author":"J Chen","year":"2022","unstructured":"Chen J, Huang Y, Ding Z, Liang X, Lu H (2022) E-test or agar dilution for metronidazole susceptibility testing of helicobacter pylori: importance of the prevalence of metronidazole resistance. Front Microbiol 13:801537. https:\/\/doi.org\/10.3389\/fmicb.2022.801537","journal-title":"Front Microbiol"},{"issue":"1","key":"5136_CR67","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13104-019-4877-9","volume":"13","author":"M Miftahussurur","year":"2020","unstructured":"Miftahussurur M, Fauzia KA, Nusi IA, Setiawan PB, Syam AF, Waskito LA, Doohan D, Ratnasari N, Khomsan A, Adnyana IK, Akada J, Yamaoka Y (2020) E-test versus agar dilution for antibiotic susceptibility testing of Helicobacter pylori: a comparison study. BMC Res Notes 13(1):22. https:\/\/doi.org\/10.1186\/s13104-019-4877-9","journal-title":"BMC Res Notes"},{"issue":"6","key":"5136_CR68","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1128\/aac.43.6.1484","volume":"43","author":"EJ van der Wouden","year":"1999","unstructured":"van der Wouden EJ, de Jong A, Thijs JC, Kleibeuker JH, van Zwet AA (1999) Subpopulations of helicobacter pylori are responsible for discrepancies in the outcome of nitroimidazole susceptibility testing. Anti Agents Chem 43(6):1484\u20136. https:\/\/doi.org\/10.1128\/aac.43.6.1484","journal-title":"Anti Agents Chem"},{"issue":"2","key":"5136_CR69","doi-asserted-by":"publisher","first-page":"117131","DOI":"10.1016\/j.diagmicrobio.2025.117131","volume":"114","author":"B Jiang","year":"2026","unstructured":"Jiang B, Koo SH, Ang DSW, Ang TL, Lee HZ, Tan TY (2026) Development of a real-time polymerase chain reaction (RT-PCR) assay for simultaneous detection of helicobacter pylori infection and genetic mutations associated with clarithromycin resistance: a single-center, cross-sectional study from Singapore. Diagn Microbiol Infect Dis 114(2):117131. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.117131","journal-title":"Diagn Microbiol Infect Dis"},{"key":"5136_CR70","doi-asserted-by":"publisher","first-page":"596371","DOI":"10.3389\/fcimb.2020.596371","volume":"10","author":"K Egli","year":"2020","unstructured":"Egli K, Wagner K, Keller PM, Risch L, Risch M, Bodmer T (2020) Comparison of the diagnostic performance of qpcr, sanger sequencing, and whole-genome sequencing in determining clarithromycin and levofloxacin resistance in helicobacter pylori. Front Cell Infect Microbiol 10:596371. https:\/\/doi.org\/10.3389\/fcimb.2020.596371","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"5136_CR71","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41575-021-00449-x","volume":"18","author":"E Tshibangu-Kabamba","year":"2021","unstructured":"Tshibangu-Kabamba E, Yamaoka Y (2021) Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications. Nat Rev Gastroenterol Hepatol 18(9):613\u2013629. https:\/\/doi.org\/10.1038\/s41575-021-00449-x","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5136_CR72","doi-asserted-by":"publisher","unstructured":"Ram\u00edrez-L\u00e1zaro MJ, Lario S, Qu\u00edlez ME, Montserrat A, Bella MR, Junquera F, Garc\u00eda-Mart\u00ednez L, Casalots \u00c0, Parra T, and Calvet X(2020) Droplet Digital PCR Detects Low-Density Infection in a Significant Proportion of Helicobacter Pylori-Negative Gastric Biopsies of Dyspeptic Patients. Clin Transl Gastroenterol 11(6): e00184.https:\/\/doi.org\/10.14309\/ctg.0000000000000184","DOI":"10.14309\/ctg.0000000000000184"},{"issue":"5","key":"5136_CR73","doi-asserted-by":"publisher","DOI":"10.1111\/hel.70075","volume":"30","author":"SJ Inns","year":"2025","unstructured":"Inns SJ, Sowerbutts S, Yumnam B, Payne K, Wheller G, Camberis M, Mules T (2025) Droplet digital PCR-based detection of clarithromycin resistance on rapid urease test samples predicts Helicobacter pylori eradication success: a New Zealand cohort study. Helicobacter 30(5):e70075. https:\/\/doi.org\/10.1111\/hel.70075","journal-title":"Helicobacter"},{"issue":"1","key":"5136_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-72289-z","volume":"14","author":"MS Abdulrahman","year":"2024","unstructured":"Abdulrahman MS, Mansy MS, Al-Ghreib KA, Johar D, Zaky S (2024) PCR-based RFLP and ERIC-PCR patterns of Helicobacter pylori strains linked to multidrug resistance in Egypt. Sci Rep 14(1):22273. https:\/\/doi.org\/10.1038\/s41598-024-72289-z","journal-title":"Sci Rep"},{"issue":"1","key":"5136_CR75","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.sjbs.2021.09.024","volume":"29","author":"RA Hussein","year":"2022","unstructured":"Hussein RA, Al-Ouqaili MTS, Majeed YH (2022) Detection of clarithromycin resistance and 23S rRNA point mutations in clinical isolates of Helicobacter pylori isolates: phenotypic and molecular methods. Saudi J Biol Sci 29(1):513\u2013520. https:\/\/doi.org\/10.1016\/j.sjbs.2021.09.024","journal-title":"Saudi J Biol Sci"},{"key":"5136_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14121216","author":"Y Moreno Trigos","year":"2024","unstructured":"Moreno Trigos Y, Tortajada-Girb\u00e9s M, Sim\u00f3-Jord\u00e1 R, Hern\u00e1ndez P\u00e9rez M, Hortelano I, Garc\u00eda-Ferr\u00fas M, Ferr\u00fas P\u00e9rez MA (2024) Use of deep-amplicon sequencing (DAS), real-time PCR and in situ hybridization to detect H. pylori and other pathogenic Helicobacter species in feces from children. Diagnostics (Basel). https:\/\/doi.org\/10.3390\/diagnostics14121216","journal-title":"Diagnostics (Basel)"},{"key":"5136_CR77","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2304173","author":"J Vazirzadeh","year":"2020","unstructured":"Vazirzadeh J, Falahi J, Moghim S, Narimani T, Rafiei R, Karbasizadeh V (2020) Molecular assessment of resistance to clarithromycin in Helicobacter pylori strains isolated from patients with dyspepsia by fluorescent in situ hybridization in the center of Iran. BioMed Res Int. https:\/\/doi.org\/10.1155\/2020\/2304173","journal-title":"BioMed Res Int"},{"key":"5136_CR78","doi-asserted-by":"publisher","first-page":"1505166","DOI":"10.3389\/fcimb.2024.1505166","volume":"14","author":"YT Lv","year":"2024","unstructured":"Lv YT, Li D, Zhang DY, Chen SJ, Chen RX, Wang Y, Yang WZ, Gao L, Zeng JT, Xiong JX, Huang QY, Huang J, Zhang QG, Chen JJ, Bai FH (2024) Helicobacter pylori resistance in hainan province, China: investigating phenotypes and genotypes through whole-genome sequencing. Front Cell Infect Microbiol 14:1505166. https:\/\/doi.org\/10.3389\/fcimb.2024.1505166","journal-title":"Front Cell Infect Microbiol"},{"key":"5136_CR79","doi-asserted-by":"crossref","unstructured":"A Borodinov V Manoilov I Zarutsky A Petrov VJSI Kurochkin 2020 Generations of DNA sequencing methods. 4 3 20","DOI":"10.18358\/np-30-4-i320"},{"issue":"6","key":"5136_CR80","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrg.2016.49","volume":"17","author":"S Goodwin","year":"2016","unstructured":"Goodwin S, McPherson JD, McCombie WR (2016) Coming of age: ten years of next-generation sequencing technologies. Nat Rev Genet 17(6):333\u201351. https:\/\/doi.org\/10.1038\/nrg.2016.49","journal-title":"Nat Rev Genet"},{"issue":"4","key":"5136_CR81","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1128\/aac.04852-14","volume":"59","author":"TT Binh","year":"2015","unstructured":"Binh TT, Suzuki R, Trang TT, Kwon DH, Yamaoka Y (2015) Search for novel candidate mutations for metronidazole resistance in Helicobacter pylori using next-generation sequencing. Antimicrob Agents Chemother 59(4):2343\u20138. https:\/\/doi.org\/10.1128\/aac.04852-14","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"5136_CR82","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1053\/j.gastro.2021.07.012","volume":"161","author":"KG Hulten","year":"2021","unstructured":"Hulten KG, Genta RM, Kalfus IN, Zhou Y, Zhang H, Graham DY (2021) Comparison of culture with antibiogram to next-generation sequencing using bacterial isolates and formalin-fixed, paraffin-embedded gastric biopsies. Gastroenterology 161(5):1433-1442.e2. https:\/\/doi.org\/10.1053\/j.gastro.2021.07.012","journal-title":"Gastroenterology"},{"issue":"1","key":"5136_CR83","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/jcm8010053","volume":"8","author":"FN Lauener","year":"2019","unstructured":"Lauener FN, Imkamp F, Lehours P, Buissonni\u00e8re A, Benejat L, Zbinden R, Keller PM, Wagner K (2019) Genetic determinants and prediction of antibiotic resistance phenotypes in helicobacter pylori. J Clin Med 8(1):53. https:\/\/doi.org\/10.3390\/jcm8010053","journal-title":"J Clin Med"},{"issue":"1","key":"5136_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11010059","volume":"11","author":"F Haumaier","year":"2022","unstructured":"Haumaier F, Schneider-Fuchs A, Backert S, Vieth M, Sterlacci W, W\u00f6hrl BM (2022) Rapid detection of quinolone resistance mutations in gyrA of Helicobacter pylori by real-time PCR. Pathogens 11(1):59. https:\/\/doi.org\/10.3390\/pathogens11010059","journal-title":"Pathogens"},{"issue":"2","key":"5136_CR85","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12472","volume":"23","author":"S Talarico","year":"2018","unstructured":"Talarico S, Korson AS, Leverich CK, Park S, Jalikis FG, Upton MP, Broussard E, Salama NR (2018) High prevalence of Helicobacter pylori clarithromycin resistance mutations among Seattle patients measured by droplet digital PCR. Helicobacter 23(2):e12472. https:\/\/doi.org\/10.1111\/hel.12472","journal-title":"Helicobacter"},{"issue":"9","key":"5136_CR86","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.14309\/ajg.0000000000002968","volume":"119","author":"WD Chey","year":"2024","unstructured":"Chey WD, Howden CW, Moss SF, Morgan DR, Greer KB, Grover S, Shah SC (2024) ACG clinical guideline: treatment of helicobacter pylori infection. Am J Gas 119(9):1730\u20131753","journal-title":"Am J Gas"},{"key":"5136_CR87","doi-asserted-by":"publisher","unstructured":"Medel-Jara PA, Latorre G, Fuentes-Lopez E, Pizarro M, Viviani P, Chahu\u00e1n J, Maquil\u00f3n S, Corsi O, Reyes D, Espino A, Vargas JI, Wichmann IA, Harris P, Serrano C, Buruato I, Sandoval C, Varela NM, Cerpa L, Qui\u00f1ones L, Megraud F, Huang RJ, Shah SC, and Perez AR(2026) Comparison between optimized bismuth quadruple therapy and standard clarithromycin-based triple therapy for first-line Helicobacter pylori eradication: a double-blind randomized controlled trial. The Lancet Regional Health \u2013 Americas 53.https:\/\/doi.org\/10.1016\/j.lana.2025.101312","DOI":"10.1016\/j.lana.2025.101312"},{"key":"5136_CR88","doi-asserted-by":"publisher","unstructured":"Bang CS, Kang SJ, Lim H, Kim SH, Lee MW, Nam SY, Tae CH, Kim SE, Kim SY, Jung HK, Kim BJ, Choi M, Jung HY, and Kim BW(2026) Evidence-Based Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Korea: 2025 Revised Edition. Helicobacter 31(4): e70149.https:\/\/doi.org\/10.1111\/hel.70149","DOI":"10.1111\/hel.70149"},{"key":"5136_CR89","doi-asserted-by":"publisher","first-page":"175628482513780","DOI":"10.1177\/17562848251378066","volume":"18","author":"WC Tai","year":"2025","unstructured":"Tai WC, Lu LS, Yang SC, Wang HM, Wu CK, Yao CC, Huang PY, Lee YC, Chuah SK, Liang CM (2025) Comparative efficacy and safety of vonoprazan versus esomeprazole-based high-dose dual therapies for first-line Helicobacter pylori eradication: a randomized controlled trial. Ther Adv Gas 18:17562848251378066. https:\/\/doi.org\/10.1177\/17562848251378066","journal-title":"Ther Adv Gas"},{"issue":"1","key":"5136_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-026-13387-3","volume":"26","author":"H Wang","year":"2026","unstructured":"Wang H, Fei C, Cao Y, Cui G, Zhao J, Yang W, Xi M, Wang X, Gao J, Zhang Z (2026) Vonoprazan versus rabeprazole in dual therapy with amoxicillin for Helicobacter pylori eradication: a prospective, multicenter, open-label, randomized controlled trial. BMC Infect Dis 26(1):1069. https:\/\/doi.org\/10.1186\/s12879-026-13387-3","journal-title":"BMC Infect Dis"},{"issue":"9","key":"5136_CR91","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1093\/jac\/dkae224","volume":"79","author":"CG Guo","year":"2024","unstructured":"Guo CG, Jiang F, Li Y, Chen Y, Wu J, Zhang S, Leung WK (2024) Real-world efficacy of second-line therapies for helicobacter pylori: a population-based study. J Antimicrob Chemother 79(9):2263\u20132272. https:\/\/doi.org\/10.1093\/jac\/dkae224","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"5136_CR92","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1365-2036.2011.04937.x","volume":"35","author":"JP Gisbert","year":"2012","unstructured":"Gisbert JP, Calvet X (2012) Review article: rifabutin in the treatment of refractory Helicobacter pylori infection. Aliment Pharmacol Ther 35(2):209\u201321","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"5136_CR93","doi-asserted-by":"publisher","first-page":"e70009","DOI":"10.1111\/hel.70009","volume":"30","author":"YX Liu","year":"2025","unstructured":"Liu YX, Liu HN, Liu HQ, Yang YY, Cui HL, Fan LL, Sun WJ, Mei H, Wang XW, Yan G, Lan CH (2025) Vonoprazan-amoxicillin dual therapy versus drug sensitivity-based individualized therapy as a rescue regimen for helicobacter pylori infection: a multicenter. Random Control Trial Helico 30(1):e70009. https:\/\/doi.org\/10.1111\/hel.70009","journal-title":"Random Control Trial Helico"},{"issue":"7","key":"5136_CR94","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1053\/j.gastro.2026.01.008","volume":"170","author":"W Gao","year":"2026","unstructured":"Gao W, Li J, Yang G, Du S, Ling T, Zhang X, Ye H, Xiong Y, Tian Y, Liu J, Liu B, Wang C, Cheng H (2026) Vonoprazan-tetracycline dual regimen as rescue therapy for Helicobacter pylori infection: randomized controlled trial. Gastroenterology 170(7):1473\u20131483. https:\/\/doi.org\/10.1053\/j.gastro.2026.01.008","journal-title":"Gastroenterology"},{"issue":"7","key":"5136_CR95","doi-asserted-by":"publisher","first-page":"e24885","DOI":"10.1002\/jcla.24885","volume":"37","author":"Y Lin","year":"2023","unstructured":"Lin Y, Shao Y, Yan J, Ye G (2023) Antibiotic resistance in helicobacter pylori: from potential biomolecular mechanisms to clinical practice. J Clin Lab Anal 37(7):e24885. https:\/\/doi.org\/10.1002\/jcla.24885","journal-title":"J Clin Lab Anal"},{"issue":"9","key":"5136_CR96","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1136\/gutjnl-2022-327745","volume":"71","author":"P Malfertheiner","year":"2022","unstructured":"Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou JM, Schulz C, Gasbarrini A, Hunt RH, Leja M, O\u2019Morain C, Rugge M, Suerbaum S, Tilg H, Sugano K, El-Omar EM (2022) Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report. Gut 71(9):1724\u20131762","journal-title":"Gut"},{"issue":"27","key":"5136_CR97","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.3748\/wjg.v24.i27.3021","volume":"24","author":"A Iannone","year":"2018","unstructured":"Iannone A, Giorgio F, Russo F, Riezzo G, Girardi B, Pricci M, Palmer SC, Barone M, Principi M, Strippoli GF, Di Leo A, Ierardi E (2018) New fecal test for non-invasive helicobacter pylori detection: a diagnostic accuracy study. World J Gas 24(27):3021\u20133029. https:\/\/doi.org\/10.3748\/wjg.v24.i27.3021","journal-title":"World J Gas"},{"issue":"9","key":"5136_CR98","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/ueg2.12473","volume":"11","author":"MC Mommersteeg","year":"2023","unstructured":"Mommersteeg MC, Nieuwenburg SAV, Wolters LMM, Roovers B, van Vuuren HAJ, Verhaar AP, Bruno MJ, Kuipers EJ, Peppelenbosch MP, Spaander MCW, Fuhler GM (2023) The use of non-invasive stool tests for verification of helicobacter pylori eradication and clarithromycin resistance. Unit European Gas J 11(9):894\u2013903. https:\/\/doi.org\/10.1002\/ueg2.12473","journal-title":"Unit European Gas J"},{"issue":"1","key":"5136_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61329-5","volume":"16","author":"K Higgins","year":"2025","unstructured":"Higgins K, Nyssen OP, Southern J, Laponogov I, Veselkov D, Gisbert JP, Kanonnikoff TF, Veselkov K (2025) The Helicobacter pylori AI-clinician harnesses artificial intelligence to personalise H. pylori treatment recommendations. Nat Commun 16(1):6472. https:\/\/doi.org\/10.1038\/s41467-025-61329-5","journal-title":"Nat Commun"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-05136-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-026-05136-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-05136-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:42:05Z","timestamp":1792431725000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-026-05136-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,19]]},"references-count":99,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["5136"],"URL":"https:\/\/doi.org\/10.1007\/s00284-026-05136-1","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,19]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"598"}}